Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

Europe - EPA:CROS - FR0000050395 - Common Stock

10.6 EUR
+0.85 (+8.72%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

5

Overall CROS gets a fundamental rating of 5 out of 10. We evaluated CROS against 74 industry peers in the Real Estate Management & Development industry. CROS has an excellent financial health rating, but there are some minor concerns on its profitability. CROS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
CROS had a positive operating cash flow in the past year.
CROS had positive earnings in 4 of the past 5 years.
CROS had a positive operating cash flow in 4 of the past 5 years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

The Return On Assets of CROS (5.39%) is better than 89.19% of its industry peers.
Looking at the Return On Equity, with a value of 6.53%, CROS is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
CROS has a worse Return On Invested Capital (0.22%) than 63.51% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CROS is below the industry average of 3.81%.
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROIC 0.22%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 615.20%, CROS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CROS has grown nicely.
The Operating Margin of CROS (29.62%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CROS has declined.
CROS has a Gross Margin of 65.77%. This is comparable to the rest of the industry: CROS outperforms 58.11% of its industry peers.
CROS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CROS is destroying value.
The number of shares outstanding for CROS remains at a similar level compared to 1 year ago.
The number of shares outstanding for CROS remains at a similar level compared to 5 years ago.
The debt/assets ratio for CROS has been reduced compared to a year ago.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.91 indicates that CROS is not in any danger for bankruptcy at the moment.
CROS's Altman-Z score of 4.91 is amongst the best of the industry. CROS outperforms 95.95% of its industry peers.
CROS has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.07, CROS belongs to the top of the industry, outperforming 98.65% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that CROS is not too dependend on debt financing.
CROS has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. CROS outperforms 93.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 4.91
ROIC/WACC0.03
WACC7.79%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

CROS has a Current Ratio of 3.20. This indicates that CROS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CROS (3.20) is better than 77.03% of its industry peers.
A Quick Ratio of 3.20 indicates that CROS has no problem at all paying its short term obligations.
CROS has a better Quick ratio (3.20) than 79.73% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 3.2
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

CROS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 405.11%, which is quite impressive.
Measured over the past years, CROS shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.78% on average per year.
The Revenue for CROS has decreased by -11.55% in the past year. This is quite bad
The Revenue for CROS have been decreasing by -10.37% on average. This is quite bad
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.78 indicates a rather expensive valuation of CROS.
Compared to the rest of the industry, the Price/Earnings ratio of CROS indicates a somewhat cheap valuation: CROS is cheaper than 62.16% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, CROS is valued a bit cheaper.
Industry RankSector Rank
PE 20.78
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CROS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 72.84
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CROS has a Yearly Dividend Yield of 2.14%.
CROS's Dividend Yield is comparable with the industry average which is at 7.70.
Compared to an average S&P500 Dividend Yield of 2.38, CROS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.14%

5.2 History

The dividend of CROS is nicely growing with an annual growth rate of 156.54%!
Dividend Growth(5Y)156.54%
Div Incr Years0
Div Non Decr Years0
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

CROS pays out 19.46% of its income as dividend. This is a sustainable payout ratio.
DP19.46%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M
CROS.PA Dividend Payout.CROS.PA Dividend Payout, showing the Payout Ratio.CROS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

CROSSWOOD

EPA:CROS (9/16/2025, 7:00:00 PM)

10.6

+0.85 (+8.72%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap112.68M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.14%
Yearly Dividend0.1
Dividend Growth(5Y)156.54%
DP19.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.78
Fwd PE N/A
P/S 126.89
P/FCF 72.84
P/OCF 55.34
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0.51
EY4.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY1.37%
OCF(TTM)0.19
OCFY1.81%
SpS0.08
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROCE 0.26%
ROIC 0.22%
ROICexc 0.23%
ROICexgc 0.23%
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
FCFM 174.21%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
ROICexc(3y)0.43%
ROICexc(5y)0.56%
ROICexgc(3y)0.43%
ROICexgc(5y)0.56%
ROCE(3y)0.52%
ROCE(5y)0.67%
ROICexcg growth 3Y-25.56%
ROICexcg growth 5Y-29.72%
ROICexc growth 3Y-25.56%
ROICexc growth 5Y-29.71%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 55.07%
Interest Coverage 3.06
Cash Conversion N/A
Profit Quality 28.32%
Current Ratio 3.2
Quick Ratio 3.2
Altman-Z 4.91
F-Score5
WACC7.79%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)39.93%
Cap/Sales(5y)36.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.21%
EBIT growth 3Y-25.77%
EBIT growth 5Y-27.97%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y723.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y475.14%
OCF growth 3Y52.86%
OCF growth 5YN/A